Human VN2R1P CRISPR gRNA in Lenti Particles
gRNA
GEEN, PExp
Lentiviral Vector
pLenti-U6-sgRNA-PGK-Neo
Ampicillin
U6 Promoter
unconjugated
Stable
Catalog No. ABIN5181917
Quick Overview for Human VN2R1P CRISPR gRNA in Lenti Particles (ABIN5181917)
Gene
VN2R1P
(Vomeronasal 2 Receptor 1 Pseudogene (VN2R1P))
Application
Genome Editing with Engineered Nucleases (GEEN), Protein Expression (PExp)
Insert
gRNA
Vector
Lentiviral Vector
Vector Backbone
pLenti-U6-sgRNA-PGK-Neo
Promoter
U6 Promoter, PGK Promoter
Bacterial Resistance
Ampicillin
Expression Type
Stable, Transient
-
-
Species
- Human
-
Purpose
- Set of 3 gRNA against VN2R1P in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
- Sequence available upon placing order
-
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with a set of 3 gRNAs (3 x 300 μL) covering different sequences of VN2R1P
-
Selectable Marker
- Neomycin
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- VN2R1P (Vomeronasal 2 Receptor 1 Pseudogene (VN2R1P))
-
Alternative Name
- VN2R1P
-
NCBI Accession
- NG_006066
Target
-
You are here:
